December 10, 2024
TOPLINE: The beneficial effect of clopidogrel monotherapy over aspirin monotherapy in patients who underwent percutaneous coronary intervention (PCI) and remained event free for 6-18 months on […]
December 6, 2024
TOPLINE: Direct oral anticoagulant (DOAC) therapy is not associated with a significantly higher risk for intracranial hemorrhage than single-agent antiplatelet therapy. However, DOACs are linked to […]
December 6, 2024
The new understanding of molecular events that drive the various forms of amyloidosis has led to the expansion of therapeutic options to prevent end-stage disease or […]
December 5, 2024
TOPLINE: Thoracic endovascular aortic repair (TEVAR) effectively treats blunt traumatic aortic injury (BTAI), with acceptable long-term survival, low reintervention rates, and early diagnosis of manageable complications […]
December 3, 2024
TOPLINE: Prasugrel is associated with lower rates of mortality, myocardial infarction (MI), and stroke than ticagrelor under conditions of routine care of patients discharged after invasive […]
December 2, 2024
Catheter ablation is fast becoming one of the safest and most effective treatments for atrial fibrillation (AF) as new technologies become increasingly available to treat a […]
December 2, 2024
CHICAGO — A randomized placebo-controlled trial testing a direct oral anticoagulant for the prevention of cognitive decline in patients with atrial fibrillation (AF) has been halted […]
November 25, 2024
CHICAGO — Edoxaban, a direct oral anticoagulant, appeared to be as effective as or more effective than warfarin in preventing thromboembolism — such as stroke, systemic […]
November 25, 2024
A small number of potentially game-changing trials in Europe and around the world could be on the verge of identifying, for the first time, a medical […]